ArticleHepatology international2026
SOX9 promotes hepatocyte proliferation via upregulating TGF-α expression during liver regeneration.
Article in Hepatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dynamic activation and dual roles of SOX9Frontiers in cell and developmental biology · 2026Article
- Post-translational modifications in hepatocellular carcinoma: mechanisms and therapeutic potential.Medical oncology (Northwood, London, England) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe liver possesses a remarkable capacity for regeneration. Previous studies have shown that SOX9/HNF4α double-positive hepatocytes play a role in chronic liver injury. Furthermore, the deletion of HNF4α results in prolonged hepatocyte proliferation following partial hepatectomy. However, the precise role of SOX9 in liver regeneration remains poorly understood.
methodsWe established acute liver injury models using standard partial hepatectomy (sHx), extended partial hepatectomy (eHx), and intraperitoneal injection of carbon tetrachloride (CCl
resultsOur study found that SOX9 expression was increased, while HNF4α expression decreased in the priming phase of acute liver injury. HNF4α suppressed SOX9 expression by upregulating miR-124/381 in hepatocytes. Deletion of SOX9 in hepatocytes resulted in a reduced liver-to-body weight ratio and impaired hepatocyte proliferation in both sHx- and CCl
conclusionsOur findings revealed that HNF4α negatively regulates SOX9 and demonstrated that SOX9 promotes hepatocyte proliferation by upregulating TGF-α levels, ultimately enhancing liver regeneration.
Indexed as
Identifiers
41182562What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.